Medicine and Dentistry
Psoriasis
65%
Atopic Dermatitis
60%
Therapeutic Procedure
42%
Dermatitis
40%
COVID-19
40%
Patient
36%
Association
34%
Child
29%
Odds Ratio
26%
Eczema
26%
Asthma
24%
Food Allergy
24%
Cross Sectional Study
20%
Skin
20%
Critical Appraisal
20%
Childhood
20%
Psoriasis Area and Severity Index
20%
Indoor Environment
20%
Serum
20%
Allergy
20%
Pediatrics
20%
Urticaria
20%
Ustekinumab
20%
Arthropathy
20%
Malassezia
16%
Inflammatory Disorder
16%
Systemic Therapy
13%
Clinician
13%
Exercise
13%
Neck
13%
Head
13%
Sensitization
13%
Public Health
12%
Targeted Therapy
11%
Morbidity
10%
Mental Disorder
10%
Immunoglobulin E
10%
Cohort Effect
10%
Health Hazard
10%
Rheumatic Disease
8%
Musculoskeletal Disease
8%
Combination Therapy
8%
Symptom
7%
Dermatosis
7%
Comorbidity
6%
Disease
6%
Family
6%
Quality of Life
6%
Disease Management
6%
Randomized Controlled Trial
6%
Immunology and Microbiology
Atopic Dermatitis
100%
Food Allergy
64%
Skin
46%
Ustekinumab
40%
Monospecific Antibody
40%
Association
38%
Sensitization
29%
Development
27%
Allergy
24%
Asthma
24%
Drug Antibody
23%
Yeast
20%
Pharmacodynamics
20%
Adalimumab
20%
Pharmacokinetics
20%
HLA-DR
20%
Childhood
20%
Eczema
20%
COVID-19
20%
Inflammation
17%
Malassezia
16%
Neck
13%
Head
13%
Immunoglobulin E
12%
Biological Product
11%
Dermatitis
10%
Mould
8%
ELISA
8%
Prevalence
7%
Sample
7%
Allergen
6%
Radioimmunoassay
6%
Evolution
5%
Position
5%
Major Histocompatibility Complex
5%
Electric Potential
5%
Drug Exposure
5%
Attention
5%
Coronavirinae
5%
Immune-Mediated Inflammatory Diseases
5%
Nursing and Health Professions
Psoriasis
100%
Ustekinumab
40%
Patient
38%
Confidence Interval
28%
Placebo
25%
Inpatient
25%
Antibody
22%
Psoriasis Area and Severity Index
22%
Combination Therapy
20%
Meta Analysis
20%
Drug Antibody
20%
Systematic Review
20%
Cross-Sectional Study
20%
Critical Appraisal
20%
Methotrexate
20%
Diseases
15%
Pandemic
15%
Odds Ratio
14%
Drug
12%
Dose
12%
Enzyme Linked Immunosorbent Assay
10%
Morbidity
10%
Health Hazard
10%
Sample
9%
Adult
7%
Depression
6%
Radioimmunoassay
6%
Drug Concentration
5%
Measurement
5%
Psoriasis Vulgaris
5%